46 related articles for article (PubMed ID: 31859178)
1. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
Nikiforova MN; Wald AI; Melan MA; Roy S; Zhong S; Hamilton RL; Lieberman FS; Drappatz J; Amankulor NM; Pollack IF; Nikiforov YE; Horbinski C
Neuro Oncol; 2016 Mar; 18(3):379-87. PubMed ID: 26681766
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.
Haberberger JF; Pegram W; Britt N; Schiavone K; Severson E; Sharaf R; Albacker LA; Williams E; Lechpammer M; Hemmerich A; Lin D; Huang RSP; Hiemenz M; Elvin J; Graf R; Lesser G; Kram D; Strowd R; Bi WL; Ramkissoon LA; Cohen MB; Reddy P; Creeden J; Ross JS; Alexander BM; Ramkissoon SH
Oncologist; 2024 Jan; 29(1):e47-e58. PubMed ID: 37619245
[TBL] [Abstract][Full Text] [Related]
3. Availability and utilization of molecular testing for primary central nervous system tumors among US hospitals.
Parker M; Kazemi F; Krishnakumar A; Horowitz MA; Myneni S; Liu A; Schreck KC; Lucas CG; Mukherjee D
J Neuropathol Exp Neurol; 2024 Jun; 83(7):579-585. PubMed ID: 38687613
[TBL] [Abstract][Full Text] [Related]
4. Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.
Zeng J; Johnson A; Shufean MA; Kahle M; Yang D; Woodman SE; Vu T; Moorthy S; Holla V; Meric-Bernstam F
JCO Clin Cancer Inform; 2019 Sep; 3():1-12. PubMed ID: 31550176
[TBL] [Abstract][Full Text] [Related]
5. Metastatic extraneural glioblastoma diagnosed with molecular testing.
Majd NK; Vo HH; Moran CA; Weathers SP; Song IW; Williford GL; Rodon J; Fu S; Tsimberidou AM
Oncologist; 2024 Jun; ():. PubMed ID: 38837109
[TBL] [Abstract][Full Text] [Related]
6. Translation into Clinical Practice of the G1-G7 Molecular Subgroup Classification of Glioblastoma: Comprehensive Demographic and Molecular Pathway Profiling.
Georgescu MM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254850
[TBL] [Abstract][Full Text] [Related]
7. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K
Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology.
Lorenz J; Rothhammer-Hampl T; Zoubaa S; Bumes E; Pukrop T; Kölbl O; Corbacioglu S; Schmidt NO; Proescholdt M; Hau P; Riemenschneider MJ
Acta Neuropathol Commun; 2020 Aug; 8(1):124. PubMed ID: 32758285
[TBL] [Abstract][Full Text] [Related]
9. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
10. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
[TBL] [Abstract][Full Text] [Related]
11. Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.
Romanidou O; Apostolou P; Kouvelakis K; Tsangaras K; Eliades A; Achilleos A; Loizides C; Lemesios C; Ioannides M; Kypri E; Koumbaris G; Papadopoulou K; Papathanasiou A; Rigakos G; Xanthakis I; Fostira F; Kotoula V; Fountzilas G; Patsalis PC
Oncol Lett; 2023 Jan; 25(1):38. PubMed ID: 36589665
[TBL] [Abstract][Full Text] [Related]
12. Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
Williams G; Llewelyn A; Thatcher R; Hardisty KM; Loddo M
PLoS One; 2022; 17(3):e0245817. PubMed ID: 35324914
[TBL] [Abstract][Full Text] [Related]
13. Potential Diagnostic Value of the Differential Expression of Histone H3 Variants between Low- and High-Grade Gliomas.
Hervás-Corpión I; Gallardo-Orihuela A; Catalina-Fernández I; Iglesias-Lozano I; Soto-Torres O; Geribaldi-Doldán N; Domínguez-García S; Luna-García N; Romero-García R; Mora-López F; Iriarte-Gahete M; Morales JC; Campos-Caro A; Castro C; Gil-Salú JL; Valor LM
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771425
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of CNS tumors for the treatment and management of disease.
Nie Q; Hsiao MC; Chandok H; Rowe S; Prego M; Meyers B; Omerza G; Hesse A; Uvalic J; Soucy M; Bergeron D; Peracchio M; Burns S; Kelly K; Rueter J; Reddi HV
J Clin Neurosci; 2020 Jan; 71():311-315. PubMed ID: 31859178
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.
Nie Q; Omerza G; Chandok H; Prego M; Hsiao MC; Meyers B; Hesse A; Uvalic J; Soucy M; Bergeron D; Peracchio M; Burns S; Kelly K; Rowe S; Rueter J; Reddi HV
Cancer Genet; 2020 Apr; 242():25-34. PubMed ID: 31992506
[TBL] [Abstract][Full Text] [Related]
16. Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay.
Selvam P; Hsiao MC; Omerza G; Bergeron D; Rowe S; Uvalic J; Soucy M; Peracchio M; Burns S; Meyers B; Prego M; Nie Q; Ananda G; Chandok H; Kelly K; Hesse A; Reddi HV
Mol Diagn Ther; 2020 Feb; 24(1):103-111. PubMed ID: 31754995
[TBL] [Abstract][Full Text] [Related]
17. Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling.
McNulty SN; Cottrell CE; Vigh-Conrad KA; Carter JH; Heusel JW; Ansstas G; Dahiya S
Hum Pathol; 2019 Apr; 86():170-181. PubMed ID: 30594748
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
